22.418 articles found

Mechanism of over-activation in direct pathway mediated by dopamine D₁ receptor in rats with levodopa-induced dyskinesia.

Cao XB, Guan Q, Xu Y, Wang L, Sun SG.

Neurosci Bull · 2006-05-01

PMID: 17704844

[Diagnosis and therapy of idiopathic Parkinson's disease].

Reichmann H.

MMW Fortschr Med · 2006-05-01

PMID: 20104716

Application of asiabell astragalus root composition in treatment of neurological disease

LIU DONGLAI.

· 2006-04-29

GINKGO BILOBA LEAVE EXTRACT HAVING NOVEL COMPOSITION USEFUL FOR PREVENTION OR TREATMENT OF ALZHEIMER'S DISEASE AND PARKINSON'S DISEASE, AND EXTRACTING AND PURIFYING METHOD THEREOF

KIM HYOUNG CHUN, KIM HYUN PYO, LEE KYUNG HEE, LEE YONG OH, KIM YOU SUN, KIM YOUNG HA, HONG JUN KEE.

· 2006-04-28

Levodopa availability improves with progression of Parkinson's disease.

Woitalla D, Goetze O, Kim JI, Nikodem AB, Schmidt WE, Przuntek H, Müller T.

J Neurol · 2006-04-28

DOI: 10.1007/s00415-006-0207-yPMID: 16649094

Prevalence of movement disorders in adolescent patients with schizophrenia and in relationship to predominantly atypical antipsychotic treatment.

Gebhardt S, Härtling F, Hanke M, Mittendorf M, Theisen FM, Wolf-Ostermann K, Grant P, Martin M, Fleischhaker C, Schulz E, Remschmidt H.

Eur Child Adolesc Psychiatry · 2006-04-28

DOI: 10.1007/s00787-006-0544-5PMID: 16648965

Method for the treatment of parkinson's disease

MANDEL RONALD J, LEFF STUART E.

· 2006-04-24

IN VIVO GENE THERAPY OF PARKINSON'S DISEASE

TORNOEE JENS, ROSENBLAD CARL, WAHLBERG LARS.

· 2006-04-20

Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized study.

Barone P, Scarzella L, Marconi R, Antonini A, Morgante L, Bracco F, Zappia M, Musch B, Depression/Parkinson Italian Study Group.

J Neurol · 2006-04-20

DOI: 10.1007/s00415-006-0067-5PMID: 16607468

Disease progression and pharmacodynamics in Parkinson disease - evidence for functional protection with levodopa and other treatments.

Holford NH, Chan PL, Nutt JG, Kieburtz K, Shoulson I, Parkinson Study Group.

J Pharmacokinet Pharmacodyn · 2006-04-20

DOI: 10.1007/s10928-006-9012-6PMID: 16625427

COMPOSITION AND DOSAGE FORM FOR SUSTAINED EFFECT OF LEVODOPA.

LERNER E ITZHAK, ROSENBERGER VERED, FLASHNER-BARAK MOSHE.

· 2006-04-19

IN VIVO GENE THERAPY OF PARKINSON'S DISEASE.

WAHLBERG LARS.

· 2006-04-19